232 related articles for article (PubMed ID: 17415527)
1. Regulation of DNA repair in hypoxic cancer cells.
Bindra RS; Crosby ME; Glazer PM
Cancer Metastasis Rev; 2007 Jun; 26(2):249-60. PubMed ID: 17415527
[TBL] [Abstract][Full Text] [Related]
2. Genetic instability and the tumor microenvironment: towards the concept of microenvironment-induced mutagenesis.
Bindra RS; Glazer PM
Mutat Res; 2005 Jan; 569(1-2):75-85. PubMed ID: 15603753
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia-induced down-regulation of BRCA1 expression by E2Fs.
Bindra RS; Gibson SL; Meng A; Westermark U; Jasin M; Pierce AJ; Bristow RG; Classon MK; Glazer PM
Cancer Res; 2005 Dec; 65(24):11597-604. PubMed ID: 16357170
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia down-regulates DNA double strand break repair gene expression in prostate cancer cells.
Meng AX; Jalali F; Cuddihy A; Chan N; Bindra RS; Glazer PM; Bristow RG
Radiother Oncol; 2005 Aug; 76(2):168-76. PubMed ID: 16026872
[TBL] [Abstract][Full Text] [Related]
5. Chronic hypoxia decreases synthesis of homologous recombination proteins to offset chemoresistance and radioresistance.
Chan N; Koritzinsky M; Zhao H; Bindra R; Glazer PM; Powell S; Belmaaza A; Wouters B; Bristow RG
Cancer Res; 2008 Jan; 68(2):605-14. PubMed ID: 18199558
[TBL] [Abstract][Full Text] [Related]
6. Co-repression of mismatch repair gene expression by hypoxia in cancer cells: role of the Myc/Max network.
Bindra RS; Glazer PM
Cancer Lett; 2007 Jul; 252(1):93-103. PubMed ID: 17275176
[TBL] [Abstract][Full Text] [Related]
7. The role of hypoxia-induced factors in tumor progression.
Vaupel P
Oncologist; 2004; 9 Suppl 5():10-7. PubMed ID: 15591418
[TBL] [Abstract][Full Text] [Related]
8. Diminished DNA repair and elevated mutagenesis in mammalian cells exposed to hypoxia and low pH.
Yuan J; Narayanan L; Rockwell S; Glazer PM
Cancer Res; 2000 Aug; 60(16):4372-6. PubMed ID: 10969780
[TBL] [Abstract][Full Text] [Related]
9. Array-based comparative gene expression analysis of tumor cells with increased apoptosis resistance after hypoxic selection.
Weinmann M; Belka C; Güner D; Goecke B; Müller I; Bamberg M; Jendrossek V
Oncogene; 2005 Sep; 24(38):5914-22. PubMed ID: 15897868
[TBL] [Abstract][Full Text] [Related]
10. p53 controls prostate-derived factor/macrophage inhibitory cytokine/NSAID-activated gene expression in response to cell density, DNA damage and hypoxia through diverse mechanisms.
Kelly JA; Lucia MS; Lambert JR
Cancer Lett; 2009 May; 277(1):38-47. PubMed ID: 19100681
[TBL] [Abstract][Full Text] [Related]
11. Genetic instability in the human lymphocyte exposed to hypoxia.
Lee JH; Choi IJ; Song DK; Kim DK
Cancer Genet Cytogenet; 2010 Jan; 196(1):83-8. PubMed ID: 19963140
[TBL] [Abstract][Full Text] [Related]
12. The HIF1alpha-inducible pro-cell death gene BNIP3 is a novel target of SIM2s repression through cross-talk on the hypoxia response element.
Farrall AL; Whitelaw ML
Oncogene; 2009 Oct; 28(41):3671-80. PubMed ID: 19668230
[TBL] [Abstract][Full Text] [Related]
13. Tumor microenvironmental physiology and its implications for radiation oncology.
Vaupel P
Semin Radiat Oncol; 2004 Jul; 14(3):198-206. PubMed ID: 15254862
[TBL] [Abstract][Full Text] [Related]
14. "Contextual" synthetic lethality and/or loss of heterozygosity: tumor hypoxia and modification of DNA repair.
Chan N; Bristow RG
Clin Cancer Res; 2010 Sep; 16(18):4553-60. PubMed ID: 20823145
[TBL] [Abstract][Full Text] [Related]
15. DNA repair in response to anthracycline-DNA adducts: a role for both homologous recombination and nucleotide excision repair.
Spencer DM; Bilardi RA; Koch TH; Post GC; Nafie JW; Kimura K; Cutts SM; Phillips DR
Mutat Res; 2008 Feb; 638(1-2):110-21. PubMed ID: 17961607
[TBL] [Abstract][Full Text] [Related]
16. Taking advantage of tumor cell adaptations to hypoxia for developing new tumor markers and treatment strategies.
Ebbesen P; Pettersen EO; Gorr TA; Jobst G; Williams K; Kieninger J; Wenger RH; Pastorekova S; Dubois L; Lambin P; Wouters BG; Van Den Beucken T; Supuran CT; Poellinger L; Ratcliffe P; Kanopka A; Görlach A; Gasmann M; Harris AL; Maxwell P; Scozzafava A
J Enzyme Inhib Med Chem; 2009 Apr; 24 Suppl 1():1-39. PubMed ID: 19330638
[TBL] [Abstract][Full Text] [Related]
17. Multifaceted control of DNA repair pathways by the hypoxic tumor microenvironment.
Scanlon SE; Glazer PM
DNA Repair (Amst); 2015 Aug; 32():180-189. PubMed ID: 25956861
[TBL] [Abstract][Full Text] [Related]
18. Basic-helix-loop-helix (bHLH) transcription factor DEC2 negatively regulates vascular endothelial growth factor expression.
Sato F; Bhawal UK; Kawamoto T; Fujimoto K; Imaizumi T; Imanaka T; Kondo J; Koyanagi S; Noshiro M; Yoshida H; Kusumi T; Kato Y; Kijima H
Genes Cells; 2008 Feb; 13(2):131-44. PubMed ID: 18233956
[TBL] [Abstract][Full Text] [Related]
19. HIF-1alpha induces MXI1 by alternate promoter usage in human neuroblastoma cells.
Löfstedt T; Fredlund E; Noguera R; Navarro S; Holmquist-Mengelbier L; Beckman S; Påhlman S; Axelson H
Exp Cell Res; 2009 Jul; 315(11):1924-36. PubMed ID: 19254710
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia-induced epithelial VEGF-C/VEGFR-3 upregulation in carcinoma cell lines.
Simiantonaki N; Jayasinghe C; Michel-Schmidt R; Peters K; Hermanns MI; Kirkpatrick CJ
Int J Oncol; 2008 Mar; 32(3):585-92. PubMed ID: 18292935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
